HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chou-Chi H Li Selected Research

Neoplasms (Cancer)

10/2007Inhibitors of ubiquitin-activating enzyme (E1), a new class of potential cancer therapeutics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chou-Chi H Li Research Topics

Disease

1Inclusion Body Myopathy With Early-Onset Paget Disease And Frontotemporal Dementia
01/2015
1Neurodegenerative Diseases (Neurodegenerative Disease)
05/2008
1Neoplasms (Cancer)
10/2007
1Carcinogenesis
02/2006
1Carcinoma (Carcinomatosis)
02/2006

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
01/2015 - 05/2008
14(4- (5- nitro- furan- 2- ylmethylene)- 3,5- dioxo- pyrazolidin- 1- yl)- benzoic acid ethyl esterIBA
10/2007
1UbiquitinIBA
10/2007
1Ubiquitin-Activating Enzymes (Ubiquitin-Activating Enzyme)IBA
10/2007
1Proteasome Endopeptidase Complex (Proteasome)IBA
10/2007
1Complementary DNA (cDNA)IBA
02/2006
1hematopoietic progenitor kinase 1IBA
02/2006

Therapy/Procedure

1Therapeutics
10/2007